Radiopharmaceuticals Market Scope And Analysis

  • Report Code : TIPRE00003751
  • Category : Life Sciences
  • Status : Published
  • No. of Pages : 237
Buy Now

Radiopharmaceuticals Market Report - Analysis by 2031

Buy Now


Radiopharmaceuticals Market Report Scope

Report Attribute Details
Market size in 2023 US$ 9.07 Billion
Market Size by 2031 US$ 26.51 Billion
Global CAGR (2023 - 2031) 14.4%
Historical Data 2021-2022
Forecast period 2024-2031
Segments Covered By Application
  • Oncology
  • Cardiology
  • Neurology
  • Pulmonary
  • Urology
By Type
  • Diagnostic
  • Therapeutic
By Tracer Type
  • Tc-99m
  • F-18
  • Ga-68
  • TL-201
  • I-131
  • Fe-59
  • Lu-171
  • RB-82 and N-13
  • Cr-51 and P-32
  • Sc-46
  • Sg-269 and Hs-269
By End User
  • Hospitals and Clinics
  • Diagnostic Centers
  • Academic and Research Institutes
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Medi Radiopharma MRP
  • Rotem Industries Ltd
  • ABX Advanced Biochemical Compounds GmbH
  • Invicro LLC
  • Cardinal Health
  • Newcastle University
  • Novartis
  • Curium
  • Blue Earth Diagnostics
  • General Electric Company